{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T14:44:58Z","timestamp":1782225898241,"version":"3.54.5"},"reference-count":36,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.ygyno.2018.01.016","type":"journal-article","created":{"date-parts":[[2018,3,2]],"date-time":"2018-03-02T01:05:47Z","timestamp":1519952747000},"page":"515-520","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Processing of fallopian tube, ovary, and endometrial surgical pathology specimens: A survey of U.S. laboratory practices"],"prefix":"10.1016","volume":"148","author":[{"given":"Goli","family":"Samimi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Britton","family":"Trabert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e1ire A.","family":"Duggan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer L.","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kisha I.","family":"Coa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Waibel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edna","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lori M.","family":"Minasian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark E.","family":"Sherman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2018.01.016_bb0005","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.ajpath.2015.11.011","article-title":"The dualistic model of ovarian carcinogenesis: revisited, revised, and expanded","volume":"186","author":"Kurman","year":"2016","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ygyno.2018.01.016_bb0010","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/01.pas.0000213335.40358.47","article-title":"Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: evidence for a causal relationship","volume":"31","author":"Kindelberger","year":"2007","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.ygyno.2018.01.016_bb0015","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1097\/IGC.0000000000000920","article-title":"Serous tubal intraepithelial carcinoma associated with extraovarian metastases","volume":"27","author":"Schneider","year":"2017","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.ygyno.2018.01.016_bb0020","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1097\/PAS.0b013e31822f58bc","article-title":"Diagnosis of serous tubal intraepithelial carcinoma based on morphologic and immunohistochemical features: a reproducibility study","volume":"35","author":"Visvanathan","year":"2011","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.ygyno.2018.01.016_bb0025","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1097\/PAS.0b013e3181868904","article-title":"Serous tubal intraepithelial carcinoma and the dominant ovarian mass: clues to serous tumor origin?","volume":"33","author":"Roh","year":"2009","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.ygyno.2018.01.016_bb0030","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/PGP.0b013e31822ea955","article-title":"Frequency of serous tubal intraepithelial carcinoma in various gynecologic malignancies: a study of 300 consecutive cases","volume":"31","author":"Tang","year":"2012","journal-title":"Int. J. Gynecol. Pathol."},{"key":"10.1016\/j.ygyno.2018.01.016_bb0035","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.ygyno.2014.01.018","article-title":"Risk reducing salpingo-oophorectomy for BRCA mutation carriers: twenty years later","volume":"132","author":"Powell","year":"2014","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2018.01.016_bb0040","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1111\/1471-0528.14543","article-title":"Serous tubal intraepithelial carcinomas associated with high-grade serous ovarian carcinomas: a systematic review","volume":"124","author":"Chen","year":"2017","journal-title":"BJOG"},{"key":"10.1016\/j.ygyno.2018.01.016_bb0045","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1038\/s41467-017-01217-9","article-title":"Molecular analysis of high-grade serous ovarian carcinoma with and without associated serous tubal intra-epithelial carcinoma","volume":"8","author":"Ducie","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ygyno.2018.01.016_bb0050","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/PGP.0000000000000336","article-title":"The fallopian tube origin and primary site assignment in extrauterine high-grade serous carcinoma: findings of a survey of pathologists and clinicians","volume":"36","author":"McCluggage","year":"2017","journal-title":"Int. J. Gynecol. Pathol."},{"key":"10.1016\/j.ygyno.2018.01.016_bb0055","author":"College of American Pathologists"},{"key":"10.1016\/j.ygyno.2018.01.016_bb0060","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/01.pas.0000180854.28831.77","article-title":"The tubal fimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome","volume":"30","author":"Medeiros","year":"2006","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.ygyno.2018.01.016_bb0065","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/modpathol.2015.77","article-title":"Data set for reporting of ovary, fallopian tube and primary peritoneal carcinoma: recommendations from the International Collaboration on Cancer Reporting (ICCR)","volume":"28","author":"McCluggage","year":"2015","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.ygyno.2018.01.016_bb0070","doi-asserted-by":"crossref","first-page":"4160","DOI":"10.1200\/JCO.2008.16.4814","article-title":"Serous tubal intraepithelial carcinoma: its potential role in primary peritoneal serous carcinoma and serous cancer prevention","volume":"26","author":"Carlson","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2018.01.016_bb0075","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1097\/PAS.0b013e3181bc6059","article-title":"Multistep level sections to detect occult fallopian tube carcinoma in risk-reducing salpingo-oophorectomies from women with BRCA mutations: implications for defining an optimal specimen dissection protocol","volume":"33","author":"Rabban","year":"2009","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.ygyno.2018.01.016_bb0080","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djx263","article-title":"Reported incidence and survival of fallopian tube carcinomas: a population-based analysis from the north American Association of Central Cancer Registries","author":"Trabert","year":"2017","journal-title":"J. Natl. Cancer Inst."},{"issue":"7","key":"10.1016\/j.ygyno.2018.01.016_bb0085","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djx269","article-title":"Precancerous lesions of ovarian cancer-a US perspective","volume":"110","author":"Visvanathan","year":"2018","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.ygyno.2018.01.016_bb0090","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.ajog.2016.07.055","article-title":"Growth in salpingectomy rates in the United States since 2000","volume":"215","author":"Hicks-Courant","year":"2016","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2018.01.016_bb0095","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1097\/GRF.0000000000000316","article-title":"Management of Preinvasive Lesions","volume":"60","author":"Patrono","year":"2017","journal-title":"Clin. Obstet. Gynecol."},{"issue":"760429","key":"10.1016\/j.ygyno.2018.01.016_bb0100","article-title":"Serous tubal intraepithelial carcinoma: an incidental finding at the time of prophylactic bilateral salpingo-oophorectomy","volume":"2015","author":"Vaughan","year":"2015","journal-title":"Case Rep. Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2018.01.016_bb0105","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1080\/14737140.2016.1247699","article-title":"Serous tubal intraepithelial carcinoma (STIC) - clinical impact and management","volume":"16","author":"Weinberger","year":"2016","journal-title":"Expert. Rev. Anticancer. Ther."},{"key":"10.1016\/j.ygyno.2018.01.016_bb0110","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.ygyno.2010.11.020","article-title":"\u201cPrimary peritoneal\u201d high-grade serous carcinoma is very likely metastatic from serous tubal intraepithelial carcinoma: assessing the new paradigm of ovarian and pelvic serous carcinogenesis and its implications for screening for ovarian cancer","volume":"120","author":"Seidman","year":"2011","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2018.01.016_bb0115","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1097\/PAS.0b013e3181ef7b16","article-title":"Are all pelvic (nonuterine) serous carcinomas of tubal origin?","volume":"34","author":"Przybycin","year":"2010","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.ygyno.2018.01.016_bb0120","author":"American College of Obstetricians and Gynecologists"},{"issue":"593","key":"10.1016\/j.ygyno.2018.01.016_bb0125","article-title":"Early salpingectomy (TUbectomy) with delayed oophorectomy to improve quality of life as alternative for risk-reducing salpingo-oophorectomy in BRCA1\/2 mutation carriers (TUBA study): a prospective non-randomised multicentre study","volume":"15","author":"Harmsen","year":"2015","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ygyno.2018.01.016_bb0130","series-title":"SEER Program Coding and Staging Manual","year":"2012"},{"key":"10.1016\/j.ygyno.2018.01.016_bb0135","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1097\/00000478-200404000-00009","article-title":"Grading ovarian serous carcinoma using a two-tier system","volume":"28","author":"Malpica","year":"2004","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.ygyno.2018.01.016_bb0140","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1097\/PAS.0b013e31825ec07a","article-title":"The diagnostic and biological implications of laminin expression in serous tubal intraepithelial carcinoma","volume":"36","author":"Kuhn","year":"2012","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.ygyno.2018.01.016_bb0145","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/PAS.0b013e3181be5d72","article-title":"HMGA2: a potential biomarker complement to P53 for detection of early-stage high-grade papillary serous carcinoma in fallopian tubes","volume":"34","author":"Wei","year":"2010","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.ygyno.2018.01.016_bb0150","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.5858\/arpa.2017-0231-RA","article-title":"Serous tubal intraepithelial carcinoma or not? Metastases to fallopian tube mucosa can masquerade as in situ lesions","volume":"141","author":"Singh","year":"2017","journal-title":"Arch. Pathol. Lab. Med."},{"issue":"8","key":"10.1016\/j.ygyno.2018.01.016_bb0155","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1001\/jamaoncol.2015.1618","article-title":"Next-generation sequencing of tubal intraepithelial carcinomas","volume":"1","author":"McDaniel","year":"2015","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.ygyno.2018.01.016_bb0160","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1158\/2159-8290.CD-16-0607","article-title":"Genomics of ovarian cancer progression reveals diverse metastatic trajectories including intraepithelial metastasis to the fallopian tube","volume":"6","author":"Eckert","year":"2016","journal-title":"Cancer Discov."},{"key":"10.1016\/j.ygyno.2018.01.016_bb0165","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/PGP.0b013e318264ae09","article-title":"Do deeper sections increase the frequency of detection of serous tubal intraepithelial carcinoma (STIC) in the \u201csectioning and extensively examining the FIMbriated end\u201d (SEE-FIM) protocol?","volume":"32","author":"Mahe","year":"2013","journal-title":"Int. J. Gynecol. Pathol."},{"key":"10.1016\/j.ygyno.2018.01.016_bb0170","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1158\/1940-6207.CAPR-15-0384","article-title":"Rationale for developing a specimen bank to study the pathogenesis of high-grade serous carcinoma: a review of the evidence","volume":"9","author":"Sherman","year":"2016","journal-title":"Cancer Prev. Res. (Phila.)"},{"key":"10.1016\/j.ygyno.2018.01.016_bb0175","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1097\/IGC.0b013e31821bc7e3","article-title":"Risk-reducing salpingo-oophorectomy (RRSO) in BRCA mutation carriers: experience with a consecutive series of 111 patients using a standardized surgical-pathological protocol","volume":"21","author":"Powell","year":"2011","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.ygyno.2018.01.016_bb0180","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1097\/PAS.0000000000000199","article-title":"Early detection of high-grade tubal serous carcinoma in women at low risk for hereditary breast and ovarian cancer syndrome by systematic examination of fallopian tubes incidentally removed during benign surgery","volume":"38","author":"Rabban","year":"2014","journal-title":"Am. J. Surg. Pathol."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825818300489?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825818300489?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,12]],"date-time":"2019-10-12T03:58:13Z","timestamp":1570852693000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825818300489"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["S0090825818300489"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2018.01.016","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Processing of fallopian tube, ovary, and endometrial surgical pathology specimens: A survey of U.S. laboratory practices","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2018.01.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}